<?xml version="1.0" encoding="UTF-8"?>
<ref id="B115-molecules-25-05905">
 <label>115.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sakai-Sugino</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Uematsu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kamada</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Taniguchi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yoshimi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kihira</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kawano</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tsurudome</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Glycyrrhizin inhibits human parainfluenza virus type 2 replication by the inhibition of genome RNA, mRNA and protein syntheses</article-title>
  <source>Drug Discov. Ther.</source>
  <year>2017</year>
  <volume>11</volume>
  <fpage>246</fpage>
  <lpage>252</lpage>
  <pub-id pub-id-type="doi">10.5582/ddt.2017.01048</pub-id>
  <pub-id pub-id-type="pmid">29070744</pub-id>
 </element-citation>
</ref>
